BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
49.08
-1.15 (-2.29%)
At close: Aug 22, 2025, 4:00 PM
49.60
+0.52 (1.06%)
After-hours: Aug 22, 2025, 7:32 PM EDT

BridgeBio Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
9,3835,1867,0231,1392,4558,716
Upgrade
Market Cap Growth
72.98%-26.16%516.57%-53.61%-71.83%101.23%
Upgrade
Enterprise Value
10,4846,6618,2292,2713,2648,544
Upgrade
Last Close Price
49.0827.4440.377.6216.6871.11
Upgrade
PS Ratio
39.4823.37754.9214.6735.221056.59
Upgrade
PB Ratio
--3.56-5.23-0.91-2.8480.79
Upgrade
P/TBV Ratio
-----150.52
Upgrade
EV/Sales Ratio
44.4630.02884.5129.2546.811035.70
Upgrade
Debt / Equity Ratio
-1.04-1.19-1.30-1.38-1.994.60
Upgrade
Asset Turnover
0.250.300.020.100.080.01
Upgrade
Quick Ratio
4.744.443.044.036.346.35
Upgrade
Current Ratio
5.194.673.324.526.586.72
Upgrade
Return on Equity (ROE)
------173.15%
Upgrade
Return on Assets (ROA)
-41.96%-47.83%-64.08%-35.80%-41.75%-44.42%
Upgrade
Return on Capital (ROIC)
-108.17%-104.60%-85.54%-43.72%-48.94%-50.63%
Upgrade
Earnings Yield
-8.28%-10.33%-9.16%-42.24%-22.91%-5.15%
Upgrade
FCF Yield
-7.00%-10.06%-7.53%-37.25%-20.82%-4.67%
Upgrade
Buyback Yield / Dilution
-7.74%-14.30%-10.39%-2.16%-22.34%-12.27%
Upgrade
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q